19 Facts About Eric Schadt

Eric Emil Schadt was born on January 31,1965 and is an American mathematician and computational biologist.

Eric Schadt is founder and former chief executive officer of Sema4, a patient-centered health intelligence company, and dean for precision medicine and Mount Sinai Professor in Predictive Health and Computational Biology at the Icahn School of Medicine at Mount Sinai.

Eric Schadt was previously founding director of the Icahn Institute for Genomics and Multiscale Biology and chair of the Department of Genetics and Genomics Sciences at the Icahn School of Medicine at Mount Sinai.

Eric Schadt is known for calling for a shift in molecular biology toward a network-oriented view of living systems to complement the reductionist, single-gene approaches that currently dominate biology to more accurately model the complexity of biological systems.

Eric Schadt has worked to engage the public, encouraging people to participate in scientific research and helping them understand privacy concerns around DNA-based information.

Eric Schadt went on to earn a master's degree in pure mathematics at the University of California, Davis in 1993.

Eric Schadt published some of the first independently developed algorithms to process gene chip data work that he later applied to produce an early whole genome functional annotation of the human genome.

Merck acquired Rosetta in 2001, which allowed Eric Schadt to combine large-scale molecular profiling with Merck's disease-focused databases to demonstrate the existence of molecular networks working together to give rise to complex system behavior.

In 2009, along with Stephen Friend, Eric Schadt founded Sage Bionetworks, a nonprofit organization with the goal of encouraging collaboration between academic and commercial scientists in performing network-based studies of disease and making the data publicly available.

Also in 2009, Eric Schadt joined DNA sequencing company Pacific Biosciences as the chief scientific officer.

Eric Schadt led research projects to resolve the origins of the Haitian cholera outbreak strain from 2010 and to characterize the highly virulent German E coli outbreak strain in the summer of 2011.

In 2011, Eric Schadt joined the Mount Sinai School of Medicine in New York, where he founded the new Icahn Institute for Genomics and Multiscale Biology and became chair of the Department of Genetics and Genomics Sciences.

Eric Schadt serves on the executive committee of the New York Genome Center.

Also that year, Schadt joined the Cure Alzheimer's Fund's Research Consortium along with Richard L Huganir.

Eric Schadt founded Sema4, "a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights," in June 2017.

Eric Schadt has appeared on CNN, CNBC, BBC, Bloomberg Radio, and Bloomberg TV.

The Huffington Post published a commentary by Eric Schadt, calling on scientists to incorporate information about RNA, proteins, metabolites and more into their genetic or clinical research, while asking the public to participate in research projects to help speed scientific discovery.

In 2020, Eric Schadt was named the BioCT Entrepreneur of the Year.

Eric Schadt is a highly cited author, with an h-index of 129 and more than 145,500 citations.